AAAAAA

   
Results: 1-10 |
Results: 10
Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy
Authors: Mundt, AJ McBride, R Rotmensch, J Waggoner, SE Yamada, SD Connell, PP
Citation: Aj. Mundt et al., Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy, INT J RAD O, 50(5), 2001, pp. 1145-1153
Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrialcarcinoma
Authors: Mundt, AJ Murphy, KT Rotmensch, J Waggoner, SE Yamada, SD Connell, PP
Citation: Aj. Mundt et al., Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrialcarcinoma, INT J RAD O, 50(5), 2001, pp. 1154-1160
An alpha-fetoprotein-producing hepatoid adenocarcinoma of the endometrium
Authors: Adams, SF Yamada, SD Montag, A Rotmensch, JR
Citation: Sf. Adams et al., An alpha-fetoprotein-producing hepatoid adenocarcinoma of the endometrium, GYNECOL ONC, 83(2), 2001, pp. 418-421
Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies
Authors: Mundt, AJ Roeske, JC Lujan, AE Yamada, SD Waggoner, SE Fleming, G Rotmensch, J
Citation: Aj. Mundt et al., Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies, GYNECOL ONC, 82(3), 2001, pp. 456-463
Intent-to-treat analysis of stage Ib and IIa cervical cancer in the UnitedStates: Radiotherapy or surgery 1988-1995
Authors: Brewster, WR Monk, BJ Ziogas, A Anton-Culver, H Yamada, SD Berman, ML
Citation: Wr. Brewster et al., Intent-to-treat analysis of stage Ib and IIa cervical cancer in the UnitedStates: Radiotherapy or surgery 1988-1995, OBSTET GYN, 97(2), 2001, pp. 248-254
Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus
Authors: Yamada, SD Burger, RA Brewster, WR Anton, D Kohler, MF Monk, BJ
Citation: Sd. Yamada et al., Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus, CANCER, 88(12), 2000, pp. 2782-2786
Ovarian carcinoma cell cultures are resistant to TGF-beta 1-mediated growth inhibition despite expression of functional receptors
Authors: Yamada, SD Baldwin, RL Karlan, BY
Citation: Sd. Yamada et al., Ovarian carcinoma cell cultures are resistant to TGF-beta 1-mediated growth inhibition despite expression of functional receptors, GYNECOL ONC, 75(1), 1999, pp. 72-77
Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with taxol and carboplatin
Authors: Le, TD Yamada, SD Rutgers, JL DiSaia, PJ
Citation: Td. Le et al., Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with taxol and carboplatin, GYNECOL ONC, 73(3), 1999, pp. 461-463
Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma
Authors: Bristow, RE Baldwin, RL Yamada, SD Korc, M Karlan, BY
Citation: Re. Bristow et al., Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma, CANCER, 85(3), 1999, pp. 658-668
Young age as a prognostic factor in cervical cancer: Results of a population-based study
Authors: Brewster, WR DiSaia, PJ Monk, BJ Ziogas, A Yamada, SD Anton-Culver, H
Citation: Wr. Brewster et al., Young age as a prognostic factor in cervical cancer: Results of a population-based study, AM J OBST G, 180(6), 1999, pp. 1464-1467
Risultati: 1-10 |